Back to Journals » Neuropsychiatric Disease and Treatment » Volume 8

Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study

Authors Ghaleiha A, Jahangard L, Sherafat Z, Ahmadpanah M, Brand S, Holsboer-Trachsler E, Bajoghli H, Haghighi M

Received 24 July 2012

Accepted for publication 10 August 2012

Published 14 September 2012 Volume 2012:8 Pages 407—412

DOI https://doi.org/10.2147/NDT.S36329

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Ali Ghaleiha,1 Leila Jahangard,1 Zahra Sherafat,1 Mohammad Ahmadpanah,1 Serge Brand,2 Edith Holsboer-Trachsler,2 Hafez Bajoghli,3 Mohammad Haghighi1

1Research Center for Behavioral Disorders and Substances Abuse, Hamadan University of Medical Sciences, Hamadan, Iran; 2Psychiatric Hospital of the University of Basel, Center for Affective, Stress and Sleep Disorders, University of Basel, Basel, Switzerland; 3Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran

Background: Selective serotonin reuptake inhibitors are primarily used in the pharmacological treatment of patients experiencing a major depressive disorder. However, one of the common unwanted effects is excessive sweating or hyperhidrosis. Oxybutynin is an anticholinergic medication which reduces sweating. The aim of this double-blind study was to examine the effect of administration of oxybutynin on subjective sweating in patients treated with sertraline.
Methods: A total of 140 patients experiencing a major depressive disorder (mean age 37.69 ± 10.44 years, 86 females [61.4%]) treated with sertraline (mean dose 83 mg/day) were consecutively enrolled in the study, and all reported excessive sweating as a side effect. Thereafter, the patients were randomly assigned to either an oxybutynin 5 mg/day group or to a placebo group. At the beginning and end of the 2-week trial, the patients completed questionnaires related to sweating and medication-related side effects.
Results: Over time, subjective sweating reduced significantly in the treatment group as compared with the control group. Oxybutynin-induced side effects were uncommon. Relative to male patients, female patients reported less subjective sweating.
Conclusion: Administration of oxybutynin successfully reduced excessive sweating in patients experiencing a major depressive disorder and treated with sertraline. However, possible gender effects should be taken into account.

Keywords: oxybutynin, sweating, sertraline, major depressive disorders

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Psychological distress and coping in military cadre candidates

Nakkas C, Annen H, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:2237-2243

Published Date: 29 August 2016

Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adults

Sadeghi Bahmani D, Gerber M, Kalak N, Lemola S, Clough PJ, Calabrese P, Shaygannejad V, Pühse U, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:1571-1579

Published Date: 27 June 2016

Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention

Rahimi A, Ahmadpanah M, Shamsaei F, Cheraghi F, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:1507-1515

Published Date: 22 June 2016

The current state of physical activity and exercise programs in German-speaking, Swiss psychiatric hospitals: results from a brief online survey

Brand S, Colledge F, Beeler N, Pühse U, Kalak N, Sadeghi Bahmani D, Mikoteit T, Holsboer-Trachsler E, Gerber M

Neuropsychiatric Disease and Treatment 2016, 12:1309-1317

Published Date: 3 June 2016

Validity and test–retest reliability of the Persian version of the Montgomery–Asberg Depression Rating Scale

Ahmadpanah M, Sheikhbabaei M, Haghighi M, Roham F, Jahangard L, Akhondi A, Sadeghi Bahmani D, Bajoghli H, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:603-607

Published Date: 7 March 2016

Examining Dark Triad traits in relation to mental toughness and physical activity in young adults

Sabouri S, Gerber M, Sadeghi Bahmani D, Lemola S, Clough PJ, Kalak N, Shamsi M, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:229-235

Published Date: 27 January 2016

Higher emotional intelligence is related to lower test anxiety among students

Ahmadpanah M, Keshavarz M, Haghighi M, Jahangard L, Bajoghli H, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2016, 12:133-136

Published Date: 12 January 2016

Poor mental health status and aggression are associated with poor driving behavior among male traffic offenders

Abdoli N, Farnia V, Delavar A, Esmaeili A, Dortaj F, Farrokhi N, Karami M, Shakeri J, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2015, 11:2071-2078

Published Date: 11 August 2015

Mental health status, aggression, and poor driving distinguish traffic offenders from non-offenders but health status predicts driving behavior in both groups

Abdoli N, Farnia V, Delavar A, Esmaeili A, Dortaj F, Farrokhi N, Karami M, Shakeri J, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2015, 11:2063-2070

Published Date: 10 August 2015

Impact of aerobic exercise on sleep and motor skills in children with autism spectrum disorders – a pilot study

Brand S, Jossen S, Holsboer-Trachsler E, Pühse U, Gerber M

Neuropsychiatric Disease and Treatment 2015, 11:1911-1920

Published Date: 5 August 2015

Differences in maladaptive schemas between patients suffering from chronic and acute posttraumatic stress disorder and healthy controls

Ahmadian A, Mirzaee J, Omidbeygi M, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2015, 11:1677-1684

Published Date: 10 July 2015

Perfectionism related to self-reported insomnia severity, but not when controlled for stress and emotion regulation

Brand S, Kirov R, Kalak N, Gerber M, Pühse U, Lemola S, Correll CU, Cortese S, Meyer T, Holsboer-Trachsler E

Neuropsychiatric Disease and Treatment 2015, 11:263-271

Published Date: 3 February 2015

Association between subjective actual sleep duration, subjective sleep need, age, body mass index, and gender in a large sample of young adults

Kalak N, Brand S, Beck J, Holsboer-Trachsler E, Wollmer MA

Neuropsychiatric Disease and Treatment 2015, 11:107-113

Published Date: 9 January 2015

Cortisol levels and sleep patterns in infants with orofacial clefts undergoing surgery

Mueller AA, Kalak N, Schwenzer-Zimmerer K, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2014, 10:1965-1972

Published Date: 15 October 2014

Sleep duration and subjective psychological well-being in adolescence: a longitudinal study in Switzerland and Norway

Kalak N, Lemola S, Brand S, Holsboer–Trachsler E, Grob A

Neuropsychiatric Disease and Treatment 2014, 10:1199-1207

Published Date: 3 July 2014

Perceived parenting styles differ between genders but not between elite athletes and controls

Serge Brand, Markus Gerber, Johannes Beck, et al

Adolescent Health, Medicine and Therapeutics 2011, 2:9-14

Published Date: 28 January 2011

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010